AcelRx Pharmaceuticals (NASDAQ: ACRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AcelRx Pharmaceuticals (NASDAQ: ACRX) through any online brokerage.
The latest price target for AcelRx Pharmaceuticals (NASDAQ: ACRX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ACRX to rise to within 12 months (a possible 1381.48% upside). 50 analyst firms have reported ratings in the last year.
The stock price for AcelRx Pharmaceuticals (NASDAQ: ACRX) is $0.27 last updated August 12, 2022, 8:00 PM UTC.
The next AcelRx Pharmaceuticals (ACRX) dividend date is projected to be Thursday, September 1, 2022.
AcelRx Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for AcelRx Pharmaceuticals.
AcelRx Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.